| I think its presumptuous of you to assume |
| @Motox |
09/11/2010 6:10:10 AM |
| How much market share do generics normally capture? |
| @Devarajast |
09/10/2010 8:11:35 AM |
| All-oral regimens will likely take the bulk of |
| @ravi1996 |
09/08/2010 7:08:48 PM |
| A few reasons: |
| @JOSHKEN |
09/08/2010 4:29:17 PM |
| wow missed this one! Nice!! |
| @Claytonfrankh |
09/08/2010 4:21:42 PM |
| Even if interferons stay around in HCV therapy |
| @tomlee01 |
09/08/2010 4:17:36 PM |
| I substantially disagree - but it isn't worth |
| @vegasbert |
09/08/2010 4:09:03 PM |
| You still have 136 other boards to worry |
| @johnchief |
09/08/2010 4:03:21 PM |
| Another biotech buyout & time to drop the |
| @palhivan |
09/08/2010 1:33:43 PM |
| Dew assumes a fairly high degree of probability |
| @kyle123737 |
09/08/2010 12:25:20 PM |
| Assuming you are right about the first, Hep |
| @Crusade74 |
09/08/2010 11:58:27 AM |
| They announced that they were starting a hep |
| @lucmarin89 |
09/08/2010 6:16:52 AM |
| They announced that they were starting a hep |
| @prasadnp |
09/08/2010 5:45:34 AM |
| oh..i didnt know that..i jsut saw that shareholder |
| @ams165 |
09/08/2010 4:49:23 AM |
| Your milestone figure includes $287M of clinical/regulatory milestones |
| @newtopsilicone |
09/08/2010 2:25:58 AM |
| Correction, the milestones are not yet due, but |
| @RichRic |
09/08/2010 1:49:48 AM |
| This is a horrible thing. If you |
| @tdfw |
09/08/2010 1:48:41 AM |
| isnt this a good thing? why are they |
| @lsw3618 |
09/08/2010 12:04:31 AM |
| Bristol-Myers agrees to buy ZymoGenetics for $885M |
| @Cgold |
09/07/2010 11:49:27 PM |
| $ZGEN SHORT INTEREST |
| @joshgfeller |
09/07/2010 10:49:34 PM |
| ZymoGenetics Sold to Bristol-Myers Squibb for $9.75 a |
| @mypenneys |
09/07/2010 9:34:22 PM |
| It's odd that the PR does not say |
| @diamond5 |
08/25/2010 1:26:32 PM |
| 12 weeks will be up on November 17. |
| @Sandhu |
08/25/2010 1:13:11 PM |
| ZymoGenetics Announces Completion of Enrollment in Phase 2b |
| @BigBull |
08/25/2010 12:32:24 PM |
| UPDATE 1-Zymogenetics posts narrower Q2 loss, shares rise |
| @GoMotopia |
08/04/2010 12:38:59 PM |
| $ZGEN: $4.50 |
| @Biggbear |
06/25/2010 6:00:55 PM |
| Zymogenetics $ZGEN UBS Neutral Buy $6.50 |
| @arju5488 |
06/23/2010 5:59:34 PM |
| ZymoGenetics rises on analyst 'Outperform' rating |
| @markdwane |
06/10/2010 8:16:28 PM |
| ZymoGenetics skin cancer drug meets study goal |
| @garywhitaker |
06/07/2010 11:31:41 AM |
| ZymoGenetics Initiates PEG-Interferon lambda Phase 2b Clinical Trial |
| @Germishin |
06/02/2010 12:58:23 PM |
| ZymoGenetics Announces Upcoming Presentation of Positive IL-21 Phase |
| @crazypolo123 |
05/20/2010 10:44:28 PM |
| ZymoGenetics Reports First Quarter 2010 Financial Results |
| @mchase |
05/04/2010 8:10:43 PM |
| Amino acid substitution in HCV core region and |
| @Multicraft |
04/16/2010 6:28:17 PM |
| ZymoGenetics to Host Conference Call and Webcast on |
| @carsonhughes |
04/16/2010 4:16:51 PM |
| Pointer to PROVE3 Thread on another board: |
| @ravi1996 |
03/04/2010 11:59:06 AM |
| Data on Flurizan failed AD trial from Murko |
| @adamhow70 |
02/11/2010 4:13:26 AM |
| 6:10AM Zymogenetics announces new publication supports safety profile |
| @George |
02/02/2010 1:57:29 PM |
| ZymoGenetics Inc. said it has begun a public |
| @mmzhouu |
01/07/2010 1:02:43 PM |
| 4:32PM Zymogenetics and Bayer restructure RECOTHROM agreements ($ZGEN) |
| @tommoylan |
12/22/2009 4:54:13 AM |
| Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b |
| @mcnicollconn |
11/01/2009 3:31:30 PM |
| ZymoGenetics shares fall on Oppenheimer downgrade |
| @JBJ |
10/26/2009 3:33:36 PM |
| UPDATE 1-Zymogenetics says Merck Serono discontinues MS trials |
| @Orymonster |
09/28/2009 12:58:56 PM |
| has news |
| @Ryanripper28 |
01/13/2009 12:11:23 AM |
| Oversold with an Improving RSI (ZGEN) from stockcharts.com |
| @sinosa11 |
09/19/2008 12:16:32 AM |
| UBS reiterates "BUY" and reduced 12-month price target |
| @Krissy |
09/04/2008 3:42:41 PM |
| ZymoGenetics and Merck Serono Restructure Partnership |
| @NataliedHill |
09/03/2008 12:17:54 PM |
| ZymoGenetics Earns Milestone Payment for RECOTHROM(R) European Filing |
| @damaniac311 |
09/02/2008 1:20:39 PM |
| ZymoGenetics Reports Second Quarter 2008 Financial Results |
| @nap |
08/06/2008 1:47:58 PM |
| The funds seem to still be in ZGEN |
| @marketstatsville |
07/20/2008 3:58:11 PM |
| Surf thanks for keeping the board active. It |
| @2284DM |
07/01/2008 1:27:32 AM |